Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01DE028172-03
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
FWCI
0.65
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals